230 results on '"Baumann, M. A."'
Search Results
2. Reduced diffusion in white matter after radiotherapy with photons and protons
3. Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC)
4. MO-0139 PORT-C improves LRC in a subset of patients with intermediate-risk HNSCC: A matched pair analysis
5. OC-0256 Biomarker development from joint analyses of HNSCC xenografts and patients treated by PORT-C
6. OC-0062 Potential predictive biomarkers for Nimorazole-modified radiochemotherapy in head and neck cancer
7. PD-0834 Radiotherapy versus radiochemotherapy in HPV positive and negative HNSCC xenograft models
8. PD-0830 GPD1 high expression in glioblastoma stem cells confers radiation resistance
9. OC-0638 Integrated radiogenomics analyses for outcome prognosis in patients with locally advanced HNSCC
10. PD-0835 Bone-tropic circulating tumor cell population in mCRPC patients under ablative radiotherapy
11. PO-1332 OLI-P trial: pattern of progression after radiotherapy in PSMA-PET positive METs of prostate cancer
12. OC-0277 A 6-gene signature for loco-regional control prognosis in HNSCC patients treated by PORT-C
13. OC-0691: Cerebellar volume reduction after photon or proton radio(chemo)therapy of glioblastoma patients
14. OC-0570: Validating gene signatures in locally advanced HNSCC patients treated by PORT-C and in xenografts
15. PO-1540: Radiomic models for validation in patients with locally advanced HNSCC treated with primary RTCx
16. OC-0448: Epigenetic regulation and cellular plasticity in response to irradiation in head and neck cancer
17. SP-0001: The world needs new knowledge
18. Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCC
19. Adjuvant inhibition of the epidermal growth factor receptor after fractionated irradiation of FaDu human squamous cell carcinoma
20. Updated European core curriculum for radiotherapists (radiation oncologists). Recommended curriculum for the specialist training of medical practitioners in radiotherapy (radiation oncology) within Europe
21. OC-0496 Deep-learning based estimation of locoregional control for patients with locally advanced HNSCC
22. PO-1089 Improvement and optimization of γH2AX foci assay as a predictive tool for radiation sensitivity
23. PV-0361 Minor changes in neurocognition and quality of life after proton therapy for brain tumour patients
24. OC-0390 TCGA molecular subclassification is prognostic for LRC of HNSCC after postoperative RCTx
25. OC-0582: Gene signatures predict loco-regional control after postoperative radiochemotherapy in HNSCC
26. OC-0269: Comparison of tumour hypoxia measured by FMISO-PET and gene signatures for patients with HNSCC
27. OC-0594: Postoperative [11C]MET-PET predicts radiochemotherapy outcome in glioblastoma: a prospective trial
28. OC-0508: Identification of tumour sub-volumes for improved radiomic risk modelling in locally advanced HNSCC
29. OC-0152: Glutamine metabolism as potential biomarker and target for prostate cancer radiosensitization
30. OC-0324: Immune contexture in SCCHN and outcome after chemoradiotherapy in an uni- and multicentric cohort
31. OC-0588: Validation of the reRT risk score (RRRS) in glioma patients: A multicenter DKTK/ROG analysis
32. OC-0511: NTCP modelling and external validation of early side effects for proton therapy of brain tumours
33. OC-0276: Combining different genomic signatures to improve the prognostic power for LRC after PORT-C in HNSCC
34. PO-1050: Color Coded HNSCC Tumor Cells for Clonal Tracing of Radioresistance
35. PO-0895: MRI-based analysis of volumetric changes of healthy brain tissue in glioma patients after photon RT
36. PO-0819: Robustness evaluation of single- and multifield optimized proton plans for unilateral head and neck
37. EP-1065: Prediction of Dysphagia and Xerostomia based on CT imaging features of HNSCC Patients
38. PO-0619: Comparison of a nanoString and RNA microarray gene signature predicting LRC after PORT-C in HNSCC
39. PO-0968: The Role of epithelial to mesenchymal transition (EMT) as Biomarker for Radioresistance in HNSCC
40. EP-1595: NTCP models for early toxicities in patients with prostate or brain tumours receiving proton therapy
41. EP-1220: Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy
42. OC-0436: Cytokine-dependent regulation of prostate cancer stem cell maintenance in response to irradiation
43. OC-0244: Does the RBE depend on ion type?
44. PO-0616: HPV, CSC marker expression and tumor hypoxia as prognosticators for LRC in patients with HNSCC
45. OC-0154: Clinical use of dual-energy CT for proton treatment planning to reduce CT-based range uncertainties
46. PO-0872: The variability of the RBE in proton therapy: can we base it on empirical clinical data?
47. SP-0503: European strategy
48. SP-0402: The fall and raise of predictive radiotherapy biomarkers
49. OC-0451: Tumour volume, hypoxia and cancer stem cells as prognosticators for LRC after primary RCT in HNSCC
50. PV-0428: Factor 2.5 radiosensitivity difference determined by ex vivo γH2AX assay in prostate cancer patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.